And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

Plaintiff attorney: My responsibility is to my client. I need to do the best I can. If the defense demands confidentiality ...

In a conversation about the challenges and solutions for aging adults, Google's Gemini chatbot told a user: "You are a drain ...

In this week's edition, Mathura shares her firsthand experience and opinions of being in clinic when a Georgia judge ...